CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
1.480
-0.040 (-2.63%)
Sep 15, 2026, 4:00 PM EDT - Market closed
CEL-SCI Market Cap
CEL-SCI has a market cap or net worth of $26.03 million as of September 15, 2026. Its market cap has decreased by -68.23% in one year.
Market Cap
26.03M
Enterprise Value
27.40M
1-Year Change
-68.23%
Ranking
Category
Stock Price
$1.48
ChartMarket Cap Chart
Since February 10, 1992, CEL-SCI's market cap has decreased from $126.81M to $26.03M, a decrease of -79.47%. That is a compound annual growth rate of -4.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 26.03M | -41.14% |
| Dec 31, 2025 | 44.23M | 49.58% |
| Dec 31, 2024 | 29.57M | -78.25% |
| Dec 29, 2023 | 135.95M | 32.44% |
| Dec 30, 2022 | 102.65M | -66.57% |
| Dec 31, 2021 | 307.04M | -33.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 28.80M |
| Estrella Immunopharma | 28.69M |
| TransCode Therapeutics | 28.61M |
| Evaxion | 26.10M |
| Quantum BioPharma | 25.88M |
| Actuate Therapeutics | 25.70M |
| ABVC BioPharma | 25.41M |
| Atossa Therapeutics | 25.05M |